Intelligent Bio Solutions (INBS) announced a new global distribution agreement with SMARTOX, a Texas-based leader in drug and alcohol screening services, to bring its SmarTest Patch drug detection product to international markets outside of the United States and Canada. This partnership builds on the long-standing relationship between INBS and SMARTOX, the U.S. distributor of INBS’s Intelligent Fingerprinting Drug Testing Solution in the Forensic Use Only market. “This partnership with SMARTOX is a natural progression of our relationship and enables us to extend a highly complementary technology to our existing markets,” said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. “With the SmarTest Patch now part of our product portfolio, we can better meet the evolving needs of customers in justice, rehabilitation, and workplace environments.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Launches SmarTest Patch for Drug Testing
- Intelligent Bio Solutions adds SmarTest Patch to drug testing solution portfolio
- Intelligent Bio Solutions to present PK study data on drug screening system
- IBS, Spjotgard drive adoption of fingerprint drug testing across Scandinavia
- INBS announces MWS plan to implement its Drug Screening System
